During the past decade, Sonova AG conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 2 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 2 clinical trials were completed. i.e. 15.4% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sonova AG" are "Hearing Loss" (22 trials), "Hearing Loss, Bilateral Sensorineural, Progressive" (3 trials), "Hearing Loss, Sensorineural" (3 trials), "Sensorineural Hearing Loss" (3 trials) and "Ear Anatomy" (1 trials). Many other conditions were trialed in "Sonova AG" in a lesser frequency.

Most popular intervention types in "Sonova AG" are "Device" (29 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Hearing Aid with NR(1)" (2 trials), "Hearing Aid with NR(2)" (2 trials), "Hearing Aid without NR enabled" (2 trials), "Line extension of the Phonak Audéo B product family" (2 trials) and "Audéo M90-T" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sonova AG" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Sonova AG". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Sonova AG, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sonova AG, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 30 trials that are defined as “Not Applicable".